Epizyme
ID: 5290673Epizyme is a biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease
3
Funding Rounds
$309.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| ro**** ho***** | - | - | |
| Yi Zh*** |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| vi****** ri**** | - | - | |
| Sa** Na**** | - | - | - |
| gr*** bo*** | - | - | |
| Ri***** F. Po** | - | - | |
| Ke*** Co**** | - | - | twitter instagram |
| Be** Se******** | - | - | - |
| Th**** Da**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Epizyme has raised a total of $309.5m in funding over 3 rounds.
Key Insights:
- Epizyme , November 2019: $270m
- Epizyme funding round, June 2011: $7.5m
- Epizyme Series B round: $32m
Industries
Epizyme is active in the following industries: